EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

Transglutaminase 2 in human peritoneal dialysis‐related peritoneal injury

Shunnosuke Kunoki, Masashi Ikeno, Hideki Tatsukawa, Yukinao Sakai, Hiroshi Kinashi, Keisuke Kamiya, Masafumi Suzuki, Masashi Mizuno, Makoto Yamaguchi, Hiroyuki Sasakura, Yuki Morioka, Masataka Banshodani and 7 more

Physiological Reports · 2025

DOI: 10.14814/phy2.70567 ↗

At a glance

Journal article in Physiological Reports, 2025. Written by Shunnosuke Kunoki and 18 co-authors. Institution: Department of Nephrology and Rheumatology, Aichi Medical University, Nagakute, Aichi, Japan. Major MEDLINE topics: Transglutaminases, Peritoneal Dialysis, GTP-Binding Proteins, Peritoneal Fibrosis. 51 references. The full text is freely available (open access, CC BY 4.0). Funded by: MEXT | Japan Society for the Promotion of Science (JSPS), Tsuchiya Foundation, Japanese Association of Dialysis Physicians (JAPD).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Patients undergoing long‐term peritoneal dialysis (PD) frequently develop peritoneal fibrosis and angiogenesis, leading to membrane dysfunction. Transglutaminase 2 (TG2) stabilizes the extracellular matrix against proteases. In an animal model, inhibition of TG2 reduced peritoneal fibrosis, angiogenesis, and inflammation. We investigated the expression of TG2 in 163 human peritoneal membrane tissue samples, including controls, tissues exposed to conventional acidic or low‐glucose degradation product (GDP) pH‐neutral solutions, and those with peritonitis or encapsulating peritoneal sclerosis (EPS), and explored the role of TG2 in high‐glucose–induced pathophysiology in mesothelial cells. TG2 expression was upregulated in association with peritoneal membrane injury and was the highest in peritonitis. TG2 expression was correlated with peritoneal membrane thickness, CD68‐positive macrophages, and myofibroblast expression. TG2 was expressed in mesothelial cells, α‐smooth muscle actin‐positive myofibroblast expression, macrophages, and endothelial cells in the diseased state. In cultured mesothelial cells, high‐glucose–induced upregulation of collagen 1, TGF‐β1, and TG2 was suppressed by a TG2 inhibitor or by TGF‐β1 small interfering RNA. TG2 is involved in the development of peritoneal injury during PD. High‐glucose dialysate is involved in the induction of peritoneal fibrosis through the interactive regulation of TGF‐β and TG2. Targeting TG2 may offer therapeutic potential for managing PD complications and EPS.

Subjects

MeSH terms (MEDLINE)

TransglutaminasesPeritoneal DialysisGTP-Binding ProteinsPeritoneal FibrosisPeritoneumHumansProtein Glutamine gamma Glutamyltransferase 2MaleFemaleMiddle AgedAdultTransforming Growth Factor beta1GlucoseDialysis SolutionsPeritonitisAgedCells, Cultured

Author keywords

TG2‐TGF‐β1 interactioncollagen densityperitoneal fibrosistransglutaminase 2α‐SMA

Substances

Protein Glutamine gamma Glutamyltransferase 2TransglutaminasesGTP-Binding ProteinsTransforming Growth Factor beta1GlucoseDialysis Solutions

Authors and institutions

  • Department of Nephrology and Rheumatology, Aichi Medical University, Nagakute, Aichi, Japan.
  • Department of Endocrinology, Metabolism and Nephrology, Nippon Medical School, Tokyo, Japan.
  • Department of Medical Cell Biology, Aichi Medical University, Nagakute, Aichi, Japan.
  • Cellular Biochemistry Lab, Graduate School of Pharmaceutical Sciences, Nagoya University, Nagoya, Japan.
  • Department of Nephrology, Nagoya University, Nagoya, Japan.
  • Department of Surgery and Artificial Organs, Akane-Foundation, Tsuchiya General Hospital, Hiroshima, Japan.

ORCID profiles: Yasuhiko Ito

Funding

  • MEXT | Japan Society for the Promotion of Science (JSPS)
  • Tsuchiya Foundation
  • Japanese Association of Dialysis Physicians (JAPD)
  • Japan Society for the Promotion of Science

Cite

APA

Kunoki, S., Ikeno, M., Tatsukawa, H., Sakai, Y., Kinashi, H., Kamiya, K., Suzuki, M., Mizuno, M., Yamaguchi, M., Sasakura, H., Morioka, Y., Banshodani, M., Tawada, M., Iwabu, M., Ishimoto, T., Takeuchi, K., Hitomi, K., Kawanishi, H., & Ito, Y. (2025). Transglutaminase 2 in human peritoneal dialysis‐related peritoneal injury. Physiological Reports. https://doi.org/10.14814/phy2.70567

Vancouver

Kunoki S, Ikeno M, Tatsukawa H, Sakai Y, Kinashi H, Kamiya K, et al. Transglutaminase 2 in human peritoneal dialysis‐related peritoneal injury. Physiological Reports. 2025. doi:10.14814/phy2.70567

BibTeX
@article{Kunoki2025,
  author = {Kunoki, Shunnosuke and Ikeno, Masashi and Tatsukawa, Hideki and Sakai, Yukinao and Kinashi, Hiroshi and Kamiya, Keisuke and Suzuki, Masafumi and Mizuno, Masashi and Yamaguchi, Makoto and Sasakura, Hiroyuki and Morioka, Yuki and Banshodani, Masataka and Tawada, Mitsuhiro and Iwabu, Masato and Ishimoto, Takuji and Takeuchi, Kosei and Hitomi, Kiyotaka and Kawanishi, Hideki and Ito, Yasuhiko},
  title = {Transglutaminase 2 in human peritoneal dialysis‐related peritoneal injury},
  journal = {Physiological Reports},
  year = {2025},
  doi = {10.14814/phy2.70567}
}
Start for free →